Native aortic valve endocarditis caused by Brevibacterium epidermidis in an immunocompetent patient

Am J Med Sci. 2011 Sep;342(3):257-8. doi: 10.1097/MAJ.0b013e31821ffb9f.

Abstract

Although Brevibacterium species used to be considered as nonpathogenic microorganisms until recently, it seems that they can cause a wide variety of clinical diseases by acting mostly as opportunistic pathogens. The present case is the second reported case of infective endocarditis by Brevibacterium species; however, it is the first reported infected native aortic valve in an immunocompetent patient.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actinomycetales Infections / diagnosis*
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Aortic Valve* / microbiology
  • Brevibacterium*
  • Drug Therapy, Combination
  • Endocarditis, Bacterial / diagnosis*
  • Endocarditis, Bacterial / microbiology
  • Gentamicins / administration & dosage
  • Gentamicins / therapeutic use
  • Heart Valve Diseases / diagnosis*
  • Heart Valve Diseases / microbiology
  • Humans
  • Immunocompetence
  • Male
  • Middle Aged
  • Vancomycin / administration & dosage
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Vancomycin